Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Higher subcortical and white matter cerebral blood flow in perinatally HIV-infected children.

Blokhuis C, Mutsaerts HJ, Cohen S, Scherpbier HJ, Caan MW, Majoie CB, Kuijpers TW, Reiss P, Wit FW, Pajkrt D.

Medicine (Baltimore). 2017 Feb;96(7):e5891. doi: 10.1097/MD.0000000000005891.

2.

Hepatitis C virus infection, and neurological and psychiatric disorders - A review.

Yarlott L, Heald E, Forton D.

J Adv Res. 2017 Mar;8(2):139-148. doi: 10.1016/j.jare.2016.09.005. Epub 2016 Sep 19. Review.

3.

In Vivo Imaging of Human Neuroinflammation.

Albrecht DS, Granziera C, Hooker JM, Loggia ML.

ACS Chem Neurosci. 2016 Apr 20;7(4):470-83. doi: 10.1021/acschemneuro.6b00056. Epub 2016 Mar 25. Review.

4.

Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.

Sailasuta N, Ananworanich J, Lerdlum S, Sithinamsuwan P, Fletcher JL, Tipsuk S, Pothisri M, Jadwattanakul T, Jirajariyavej S, Chalermchai T, Catella S, Busovaca E, Desai A, Paul R, Valcour V; SEARCH 011 Study Group.

J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):24-30. doi: 10.1097/QAI.0000000000000779.

5.

Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.

Peluso MJ, Valcour V, Ananworanich J, Sithinamsuwan P, Chalermchai T, Fletcher JL, Lerdlum S, Chomchey N, Slike B, Sailasuta N, Gisslén M, Zetterberg H, Spudich S; RV254/SEARCH 010 and SEARCH 011 Study Teams.

J Infect Dis. 2015 Dec 1;212(11):1759-67. doi: 10.1093/infdis/jiv296. Epub 2015 May 20.

6.

Hippocampal MR spectroscopic abnormalities in a cohort of syphilitic patients with HIV and neurosyphilis infection.

Chiu PW, Mak HK, Chan Y, Chan T, Ho KM.

Am J Nucl Med Mol Imaging. 2014 Dec 15;5(1):83-94. eCollection 2015.

7.

Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb.

Li CX, Zhang X, Komery A, Li Y, Mao H, Herndon JG, Novembre FJ.

J Neurovirol. 2014 Dec;20(6):612-9. doi: 10.1007/s13365-014-0286-y. Epub 2014 Nov 7.

8.

Imaging neuroinflammation? A perspective from MR spectroscopy.

Zahr NM, Mayer D, Rohlfing T, Sullivan EV, Pfefferbaum A.

Brain Pathol. 2014 Nov;24(6):654-64. doi: 10.1111/bpa.12197.

9.

Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.

Young AC, Yiannoutsos CT, Hegde M, Lee E, Peterson J, Walter R, Price RW, Meyerhoff DJ, Spudich S.

Neurology. 2014 Oct 28;83(18):1592-600. doi: 10.1212/WNL.0000000000000932. Epub 2014 Sep 26.

10.

Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment.

Hua X, Boyle CP, Harezlak J, Tate DF, Yiannoutsos CT, Cohen R, Schifitto G, Gongvatana A, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Alger JR, Singer E, Buchthal S, Toga AW, Navia B, Thompson PM; HIV Neuroimaging Consortium.

Neuroimage Clin. 2013 Aug 3;3:132-42. doi: 10.1016/j.nicl.2013.07.009. eCollection 2013.

11.

Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregulation in HIV-infected persons and those on anti-retroviral therapy.

Munshi SU, Rewari BB, Bhavesh NS, Jameel S.

PLoS One. 2013 May 16;8(5):e64298. doi: 10.1371/journal.pone.0064298. Print 2013.

12.

Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.

Gongvatana A, Harezlak J, Buchthal S, Daar E, Schifitto G, Campbell T, Taylor M, Singer E, Algers J, Zhong J, Brown M, McMahon D, So YT, Mi D, Heaton R, Robertson K, Yiannoutsos C, Cohen RA, Navia B; HIV Neuroimaging Consortium.

J Neurovirol. 2013 Jun;19(3):209-18. doi: 10.1007/s13365-013-0162-1. Epub 2013 Apr 24.

13.

2D MR Spectroscopy Combined with Prior-Knowledge Fitting Is Sensitive to HCV-Associated Cerebral Metabolic Abnormalities.

Nagarajan R, Sarma MK, Thames AD, Castellon SA, Hinkin CH, Thomas MA.

Int J Hepatol. 2012;2012:179365. doi: 10.1155/2012/179365. Epub 2012 Jul 12.

14.

HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.

Spudich S, González-Scarano F.

Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007120. doi: 10.1101/cshperspect.a007120. Review.

15.

Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis.

Gelman BB, Lisinicchia JG, Chen T, Johnson KM, Jennings K, Freeman DH Jr, Soukup VM.

J Neuroimmune Pharmacol. 2012 Sep;7(3):686-700. doi: 10.1007/s11481-012-9345-4. Epub 2012 Mar 6.

16.

Antiretroviral adherence and the nature of HIV-associated verbal memory impairment.

Wright MJ, Woo E, Foley J, Ettenhofer ML, Cottingham ME, Gooding AL, Jang J, Kim MS, Castellon SA, Miller EN, Hinkin CH.

J Neuropsychiatry Clin Neurosci. 2011 Summer;23(3):324-31. doi: 10.1176/appi.neuropsych.23.3.324.

17.

A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations.

Pulliam L, Rempel H, Sun B, Abadjian L, Calosing C, Meyerhoff DJ.

AIDS. 2011 Sep 10;25(14):1721-6. doi: 10.1097/QAD.0b013e328349f022.

18.

Alterations in brain metabolism during the first year of HIV infection.

Lentz MR, Kim WK, Kim H, Soulas C, Lee V, Venna N, Halpern EF, Rosenberg ES, Williams K, González RG.

J Neurovirol. 2011 Jun;17(3):220-9. doi: 10.1007/s13365-011-0030-9. Epub 2011 Apr 15.

19.

Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence.

Gonzalez R, Schuster RM, Vassileva J, Martin EM.

J Clin Exp Neuropsychol. 2011 Aug;33(7):735-52. doi: 10.1080/13803395.2011.553584. Epub 2011 Jun 24.

20.

Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.

Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B; HIV Neuroimaging Consortium.

AIDS. 2011 Mar 13;25(5):625-33. doi: 10.1097/QAD.0b013e3283427da7.

Supplemental Content

Support Center